03/10/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
01/27/2025
3:07 PM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
01/16/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form PRE 14A | |
01/08/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
8:00 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
01/07/2025
8:11 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:00 PM | Citius Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CTXR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/20/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
| Form SC 13D/A | |
11/25/2024
4:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:26 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:27 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:26 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:34 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
| Form SC 13D | |
08/16/2024
3:35 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:25 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:51 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Partner with Elon Musk on Project Colossus… Before May 1st (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
05/14/2024
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
1:22 PM | BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024
3:21 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
